Governance and Remuneration: Chairman’s Introduction
Dr Edwin Hertzog
Chairman of the Nomination Committee

The Board and management team of Mediclinic are committed to maintaining strict principles of corporate governance and the highest standards of integrity and ethics, which is embedded in our corporate culture and values. Our corporate governance structures support the effective delivery of Mediclinic’s strategy and are focused on building and maintaining a sustainable business and supporting our commitment to be a responsible corporate citizen in every country and community in which the Group operates.

In the Corporate Governance Statement that follows, feedback is given on the governance framework, Board meetings and the principal activities of the Board, the composition and diversity of the Board and measures to ensure the Board’s accountability to our wider stakeholders. Every director demonstrated their commitment to Mediclinic throughout the year, through their meeting attendance and the high quality of their contributions at those meetings. An external evaluation of the Board was conducted during the year by Lintstock, the outcome of which is detailed herein. With the announcement of the appointment of Dr Ronnie van der Merwe as CEO successor to Mr Danie Meintjes from 1 June 2018, and the appointment of Dr Muhadditha Al Hashimi and Dr Felicity Harvey as independent non-executive directors during 2017, the Nomination Committee and the Board continue to demonstrate their commitment to succession planning and targeting diverse pools of talent from which to recruit the right individuals. Further, as referred to in my statement, the continued involvement of Mr Meintjes as a non-executive director from 1 August 2018 is considered by the Board to be in the best interests of the Group, its shareholders and other stakeholders in view of the wealth of knowledge and experience he has in different capacities gained over 30 years at Mediclinic.

The key elements of our governance structures include:

  • managing our business in a sustainable manner; ensuring good clinical outcomes and quality healthcare;
  • upholding strict principles of corporate governance, integrity and ethics;
  • maintaining effective risk management and internal controls;
  • engaging with our stakeholders and responding to their reasonable expectations; and
  • offering our employees competitive remuneration packages based on the principles of fairness and affordability.

further details of which are included in this Annual Report, as well as the Clinical Services Report and the Sustainable Development Report. I remain confident that the Board, supported by an effective management team and an effective governance structure, is well placed to continue to drive long-term value for stakeholders and maintaining Mediclinic’s leading position in the international healthcare market.

Dr Edwin Hertzog
Non-executive Chairman